FDA Inspection
Alembic Pharmaceuticals Limited (Units I and II)Alembic Pharmaceuticals Limited (Units I and II) – FDA Inspection, Oct 8, 2024
Record Details
This FDA Inspection record concerns Alembic Pharmaceuticals Limited (Units I and II), with an inspection on October 8, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 8, 2024
- Product Type
- Drugs
View Company Profile
ID · 56945324-5d2c-4de3-b337-fddb20579310
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1249881
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Alembic Pharmaceuticals Limited (Units I and II)
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2025 | Not classified | Office of Inspections and Investigations | |
| December 19, 2018 | Not classified | Office of Inspections and Investigations | |
| April 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alembic Pharmaceuticals Limited (Units I and II)
- FDA Inspection 1270216 - 2025-05-31
- FDA Inspection 1076862 - 2018-12-19
- FDA Inspection 1055013 - 2018-04-23
- FDA Inspection 982077 - 2016-06-29
- FDA Inspection 831397 - 2013-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.